Strategic Blueprint LLC Buys Shares of 2,867 GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Strategic Blueprint LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund acquired 2,867 shares of the company's stock, valued at approximately $224,000.

Other institutional investors have also added to or reduced their stakes in the company. LGT Financial Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 251 shares during the period. Ashton Thomas Securities LLC purchased a new position in GE HealthCare Technologies during the third quarter worth about $26,000. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Darwin Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $31,000. Finally, Continuum Advisory LLC boosted its position in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after acquiring an additional 168 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of "Moderate Buy" and a consensus target price of $96.00.

Insider Activity at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Trading Down 0.7 %

GEHC traded down $0.58 on Tuesday, hitting $86.93. 2,487,937 shares of the company were exchanged, compared to its average volume of 2,666,427. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The firm has a fifty day simple moving average of $82.97 and a two-hundred day simple moving average of $85.09. The stock has a market capitalization of $39.72 billion, a PE ratio of 23.88, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14. GE HealthCare Technologies Inc. has a 12 month low of $72.61 and a 12 month high of $94.55.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies's payout ratio is presently 3.85%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.